Passive enhanced safety surveillance of GSK’s quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season

INTRODUCTION: The European Medicines Agency requires Marketing Authorisation Holders providing seasonal influenza vaccines in Europe to conduct enhanced safety surveillance accounting for the different age groups based on the vaccine indication, in order to detect any potential increase of local and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dos Santos, Gaël, Yeakey, Anne, Shende, Vishvesh, Smith, Katie, Lin, Frederic, Zandman-van-Dijk, Elvira, Damaso, Silvia, Schmidt, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701642/
https://www.ncbi.nlm.nih.gov/pubmed/31427321
http://dx.doi.org/10.1136/bmjopen-2018-028043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701642/
https://www.ncbi.nlm.nih.gov/pubmed/31427321
http://dx.doi.org/10.1136/bmjopen-2018-028043

Ejemplares similares